Quantcast

Latest Personalized medicine Stories

2014-06-07 12:21:15

RnRMarketResearch.com adds Molecular Diagnostics Markets for Genetic Testing, Cancer Testing & Infectious Disease Testing techniques. Report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. DALLAS, June 7, 2014 /PRNewswire-iReach/ -- The technologies that constitute molecular diagnostics-like first-generation amplification, DNA probes, fluorescent in...

2014-06-04 23:13:27

Charles Cantor, PhD, professor emeritus at Boston University and former principal scientist of the Human Genome Project joined the Science Advisory Board of InSilico Medicine, Inc. Baltimore, MD (PRWEB) June 04, 2014 InSilico Medicine, Inc. announced today that Charles Cantor, Ph.D. will chair its Scientific Advisory Board. Dr. Cantor, one of the leaders of the Human Genome Project, has published more than 400 peer-reviewed articles, authored and co-authored more than 50 U.S. and...

2014-06-04 12:28:43

SAN FRANCISCO, June 4, 2014 /PRNewswire/ -- MedGenome, the leading provider of genomic diagnostics for oncology in India and a leading provider of oncological bioinformatics to the West, today announced it has raised Series A funding in the amount of $4 million from a veteran group of executives in the technology, analytics and data science sectors. The Series A round was led by Papillon Capital's Kartik Kumaramangalam and Emerge Venture's Mahesh Pratapneni. Other investors included...

2014-06-03 08:32:14

NEW YORK, June 3, 2014 /PRNewswire/ -- Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced that Vincent J. O'Neill, M.D., has been appointed as its chief medical officer. Dr. O'Neill has extensive experience in clinical trial design, regulatory issues, and personalized medicine, most recently as global head Personalized of Medicine and Companion Diagnostics at Sanofi. At Sanofi, he defined the personalized medicine...

2014-06-01 12:20:16

Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research NEW YORK and MADISON, N.J., June 1, 2014 /PRNewswire/ -- Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into...

2014-05-30 23:16:54

Dr. Bhubaneswar (Bud) Mishra joins InSilico Medicine Inc, a Baltimore-based bioinformatics and drug discovery company specializing in cancer and aging research and personalized medicine in age-related diseases. Baltimore, MD (PRWEB) May 30, 2014 InSilico Medicine, Inc, engaged in cancer and aging research for drug discovery and developing personalized approaches to extending productive longevity is proud to announce the addition of Prof. Bud Mishra to its board of scientific advisors....

2014-05-30 11:24:36

Georgia Institute of Technology A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile – based on a simple blood test – may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors. Researchers found the risk signature by comparing gene...

2014-05-28 23:12:12

Tissue diagnostics are an important set of techniques, primarily used for the diagnosis, monitoring and management of cancer. The report segments this market by technology, disease, product, end user and geography. http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html (PRWEB) May 28, 2014 The “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer,...

2014-05-28 12:30:34

Strand celebrates the largest commercial adoption of genomics in cancer care to date ROCKVILLE, Md., May 28, 2014 /PRNewswire/ -- Strand Genomics Inc. (Strand), a global leader in clinical genomics, has announced a major initiative with Health Care Global Enterprises, Ltd (HCG) to provide personalized genomics services for oncology. Strand's clinical genomics solutions for oncology offered by the Strand-Triesta Center for Cancer Genomics (Strand-Triesta) include both cancer risk...

2014-05-27 23:05:12

Emerging biotech firm appoints prominent scientist/inventor as well as distinguished scientists/entrepreneurs to enhance scientific and business capabilities. Fayetteville, Ark., and Seattle, Wash. (PRWEB) May 27, 2014 Dr. Patricia Beckmann, a prominent scientist and inventor has been appointed to the combined roles of chief scientific officer (CSO) and chief business officer (CBO) at Ascendant Dx. In addition, Dr. Mark Boguski and Dr. Isaac Kohane have joined the Scientific Advisory...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related